Filing Details

Accession Number:
0000899243-19-028342
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-02 16:05:29
Reporting Period:
2019-12-02
Accepted Time:
2019-12-02 16:05:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1513818 Aravive Inc. ARAV () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1253170 Srinivas Akkaraju C/o Aravive, Inc., River Oaks Tower
3730 Kirby Drive, Suite 1200
Houston TX 77098
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-02 133,333 $7.50 576,066 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 31,815 Direct
Footnotes
  1. The shares of common stock were purchased in a public underwritten offering completed by Aravive, Inc. on December 2, 2019. The shares are held by Samsara BioCapital, L.P. ("Samsara BioCapital"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara BioCapital. The Reporting Person disclaims beneficial ownership of these shares except to the extent of the Reporting Person's pecuniary interest therein.